These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37564954)

  • 21. Increased Risk of Benign Prostate Hyperplasia (BPH) in Patients with Gout: A Longitudinal Follow-Up Study Using a National Health Screening Cohort.
    Bang WJ; Choi HG; Kang HS; Kwon MJ; Kim JH; Kim JH; Kim SY
    Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical analysis of transurethral holmium laser enucleation in the treatment of benign prostatic hyperplasia with prostatic inflammation: A prospective research study.
    Zhou W; Mao D; Li L; Liu G; Gao G; Li H; Gao D
    Front Surg; 2022; 9():1026657. PubMed ID: 36684154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients.
    Zou C; Gong D; Fang N; Fan Y
    World J Urol; 2016 Feb; 34(2):281-9. PubMed ID: 26119349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).
    Chen ZP; Yan Y; Chen CJ; Li M; Chen C; Zhao SC; Song T; Liu T; Zou CH; Xu Q; Li X
    Andrology; 2018 Jul; 6(4):568-578. PubMed ID: 29873201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lymphocyte-to-Monocyte Ratio with Benign Prostatic Hyperplasia: A Propensity Score-Matched Analysis.
    Kang JY; Choi JD; Cho JM; Yoo TK; Park YW; Lee JH
    Urol Int; 2021; 105(9-10):811-816. PubMed ID: 33508844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.
    Hu WS; Lin CL
    Clin Cardiol; 2018 Oct; 41(10):1374-1378. PubMed ID: 30144121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical activity and benign prostatic hyperplasia.
    Platz EA; Kawachi I; Rimm EB; Colditz GA; Stampfer MJ; Willett WC; Giovannucci E
    Arch Intern Med; 1998 Nov; 158(21):2349-56. PubMed ID: 9827786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.
    Nardin M; Verdoia M; Barbieri L; De Luca G;
    Platelets; 2019; 30(5):615-623. PubMed ID: 30047817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Circadian Syndrome Predicts Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia Better Than Metabolic Syndrome in Aging Males: A 4-Year Follow-Up Study.
    Xiong Y; Zhang F; Wu C; Zhang Y; Huang X; Qin F; Yuan J
    Front Med (Lausanne); 2021; 8():715830. PubMed ID: 34621761
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
    Cyrus A; Kabir A; Goodarzi D; Talaei A; Moradi A; Rafiee M; Moghimi M; Shahbazi E; Farmani E
    Korean J Urol; 2014 Dec; 55(12):814-20. PubMed ID: 25512816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between 23 urinary metals and mean platelet volume among a community-dwelling population in Wuhan, China].
    Feng W; He XS; Yu YQ; Li-Gu Y; Zhang XM; Yuan J; Chen WH; Wu TC
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Aug; 50(8):689-97. PubMed ID: 27539521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between mean platelet volume and metabolic syndrome in patients with type 2 diabetes mellitus: A retrospective study.
    Ding Q; Wang F; Guo X; Liang M
    Medicine (Baltimore); 2021 Apr; 100(13):e25303. PubMed ID: 33787620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary prostate-specific antigen: predictor of benign prostatic hyperplasia progression?
    Pejcic TP; Tulic CDz; Lalic NV; Glisic BD; Ignjatovic SD; Markovic BB; Hadzi-Djokic JB
    Can J Urol; 2013 Apr; 20(2):6707-13. PubMed ID: 23587511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang Y; Zhang C; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    PLoS One; 2014; 9(5):e96651. PubMed ID: 24801211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
    Ørsted DD; Bojesen SE; Nielsen SF; Nordestgaard BG
    Eur Urol; 2011 Oct; 60(4):691-8. PubMed ID: 21705134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
    Meigs JB; Mohr B; Barry MJ; Collins MM; McKinlay JB
    J Clin Epidemiol; 2001 Sep; 54(9):935-44. PubMed ID: 11520654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
    Wang JY; Fu YY; Kang DY
    Medicine (Baltimore); 2016 May; 95(19):e3243. PubMed ID: 27175628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.